- Home
- CATX vs LANV Comparison
CATX vs LANV Comparison
Compare CATX & LANV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATX
- LANV
- Stock Information
- Founded
- CATX 1983
- LANV 2015
- Country
- CATX United States
- LANV China
- Employees
- CATX N/A
- LANV N/A
- Industry
- CATX Medical/Dental Instruments
- LANV Blank Checks
- Sector
- CATX Health Care
- LANV Finance
- Exchange
- CATX Nasdaq
- LANV Nasdaq
- Market Cap
- CATX 239.0M
- LANV 264.3M
- IPO Year
- CATX N/A
- LANV N/A
- Fundamental
- Price
- CATX $3.04
- LANV $2.10
- Analyst Decision
- CATX Strong Buy
- LANV
- Analyst Count
- CATX 11
- LANV 0
- Target Price
- CATX $12.90
- LANV N/A
- AVG Volume (30 Days)
- CATX 696.8K
- LANV 44.6K
- Earning Date
- CATX 11-11-2025
- LANV 08-29-2025
- Dividend Yield
- CATX N/A
- LANV N/A
- EPS Growth
- CATX N/A
- LANV N/A
- EPS
- CATX N/A
- LANV N/A
- Revenue
- CATX $1,235,000.00
- LANV $341,783,911.00
- Revenue This Year
- CATX N/A
- LANV $11.74
- Revenue Next Year
- CATX N/A
- LANV $11.11
- P/E Ratio
- CATX N/A
- LANV N/A
- Revenue Growth
- CATX N/A
- LANV N/A
- 52 Week Low
- CATX $1.60
- LANV $1.32
- 52 Week High
- CATX $14.19
- LANV $2.69
- Technical
- Relative Strength Index (RSI)
- CATX 37.52
- LANV 44.34
- Support Level
- CATX $3.33
- LANV $1.81
- Resistance Level
- CATX $3.74
- LANV $2.40
- Average True Range (ATR)
- CATX 0.25
- LANV 0.13
- MACD
- CATX -0.01
- LANV -0.01
- Stochastic Oscillator
- CATX 2.41
- LANV 25.00
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
About LANV Lanvin Group Holdings Limited
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the Wolford segment.